APAC Contract Pharmaceutical Packaging Market - Industry Trends and Forecast to 2030

APAC Contract Pharmaceutical Packaging Market - Industry Trends and Forecast to 2030


Asia-Pacific contract pharmaceutical packaging market is expected to reach USD 2,688,413.62 Thousand by 2030 from USD 1,501,794.32 Thousand in 2022, growing at a CAGR of 7.7% in the forecast period of 2023 to 2030

Market Segmentation:
Asia-Pacific Contract Pharmaceutical Packaging Market, By Type (Primary Packaging System, Secondary Packaging System, and Tertiary Packaging System), Raw Material (Plastic & Polymers, Glass, Metals, Paper & Board, Rubber, Cotton, and Others), Application (Transmucosal Drug Delivery Packaging, Pulmonary Drug Delivery Packaging, Nasal Drug Delivery Packaging, Topical Drug Delivery Packaging, Injectable Packaging, Oral Drug Delivery Packaging, and Others), Country (China, India, Japan, South Korea, Australia and New Zealand, Indonesia, Singapore, Malaysia, Thailand, Philippines, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2030

Overview of Asia-Pacific Contract Pharmaceutical Packaging Market Dynamics

Driver
• Impact of regulatory compliance and quality assurance demands
Restraint
• Sustainability concerns due to usage of plastics in packaging materials

Opportunity

• Rising need for biopharmaceutical cold chain packaging


Market Players:

Some of the key market players operating in the Asia-Pacific contract pharmaceutical packaging market are:
• AbbVie Inc
• PCI Pharma Services
• Nelipak Healthcare
• Sharp Services, LLC
• Aphena Pharma Solutions
• ROPACK INC.
• SilganUnicep
• Reed-Lane,
• Jones Healthcare Group
• Wasdell Packaging Group
• SternMaid &Co. KG
• Sepha
• Tripak Pharmaceuticals
• Assemblies Unlimited, Inc.
• AmeriPac
• Tjoapack


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modeling
2.7 Primary Interviews With Key Opinion Leaders
2.8 Dbmr Market Position Grid
2.9 Market Application Coverage Grid
2.10 Dbmr Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestle Analysis
4.1.1 Political Factors:
4.1.2 Economic Factors:
4.1.3 Social Factors:
4.1.4 Technological Factors:
4.1.5 Legal Factors:
4.1.6 Environmental Factors:
4.2 Porter’s Five Forces
4.3 Vendor Selection Criteria 38 
5 Dynamics Of Raw Material Preferences
5.1 Plastic And Polymers:
5.1.1 Hdpe (High-density Polyethylene):
5.1.2 Ldpe (Low-density Polyethylene):
5.1.3 Pet (Polyethylene Terephthalate):
5.1.4 Pvc (Polyvinyl Chloride):
5.1.5 Pp (Polypropylene):
5.1.6 Coc (Cyclic Olefin Copolymer):
5.2 Glass:
5.2.1 Type Iv-np (General Purpose Soda Lime Glass):
5.2.2 Type I (Borosilicate Glass):
5.2.3 Type Iii (Regular Soda-lime Glass):
5.2.4 Treated Soda Lime Glass:
5.3 Metal:
5.3.1 Tin:
5.3.2 Iron:
5.3.3 Aluminium:
5.3.4 Lead:
5.4 Paper And Board:
5.4.1 Solid Board:
5.4.2 Chipboard:
5.4.3 Cardboard:
5.4.4 Fiber Board:
5.5 Rubber:
5.5.1 Natural Rubber In Contract Pharmaceutical Packaging:
5.5.2 Neoprene Rubber In Contract Pharmaceutical Packaging:
5.5.3 Butyl Rubber In Contract Pharmaceutical Packaging:
6 Partnership Details
7 Technological Advancements
8 Market Overview
8.1 Drivers
8.1.1 Strong Spending Towards Pharma Industry
8.1.2 Impact Of Complex Drug Formulations And Specialized Packaging Needs
8.1.3 Impact Of Regulatory Compliance And Quality Assurance Demands
8.2 Restraints
8.2.1 Availability Of Choice Of In-house Packaging From Manufacturers
8.2.2 Sustainability Concerns Due To Usage Of Plastics In Packaging Materials 54 
8.3 Opportunities
8.3.1 Technological Advancements In Packaging Machinery And Materials
8.3.2 Rising Need For Biopharmaceutical Cold Chain Packaging
8.4 Challenge
8.4.1 Diverse Concerns Related To Operational Hurdles
9 Asia-pacific Contract Pharmaceutical Packaging Market: By Region
9.1 Asia-pacific
10 Asia-pacific Contract Pharmaceutical Packaging Market: Company Landscape
10.1 Company Share Analysis: Asia-pacific
11 Swot Analysis
12 Company Profile
12.1 Abbvie Inc.
12.1.1 Company Snapshot
12.1.2 Revenue Analysis
12.1.3 Company Share Analysis
12.1.4 Service Portfolio
12.1.5 Recent Developments
12.2 Pci Pharma Services
12.2.1 Company Snapshot
12.2.2 Company Share Analysis
12.2.3 Service Portfolio
12.2.4 Recent Developments
12.3 Nelipak Corporation
12.3.1 Company Snapshot
12.3.2 Company Share Analysis
12.3.3 Product Portfolio
12.3.4 Recent Developments
12.4 Sharp Services, Llc
12.4.1 Company Snapshot
12.4.2 Company Share Analysis
12.4.3 Product Portfolio
12.4.4 Recent Developments 69 
12.5 Aphena Pharma Solutions
12.5.1 Company Snapshot
12.5.2 Company Share Analysis
12.5.3 Service Portfolio
12.5.4 Recent Development
12.6 Ameripac
12.6.1 Company Snapshot
12.6.2 Product Portfolio
12.6.3 Recent Development
12.7 Assemblies Unlimited, Inc.
12.7.1 Company Snapshot
12.7.2 Service Portfolio
12.7.3 Recent Development
12.8 Jones Healthcare Group
12.8.1 Company Snapshot
12.8.2 Product Portfolio
12.8.3 Recent Development
12.9 Reed-lane
12.9.1 Snapshot
12.9.2 Product Portfolio
12.9.3 Recent Development
12.10 Ropack Inc.
12.10.1 Company Snapshot
12.10.2 Product Portfolio
12.10.3 Recent Development
12.11 Sepha
12.11.1 Company Snapshot
12.11.2 Product Portfolio
12.11.3 Recent Developments
12.12 Silganunicep
12.12.1 Company Snapshot
12.12.2 Service Portfolio
12.12.3 Recent Developments
12.13 Sternmaid Gmbh & Co. Kg
12.13.1 Company Snapshot
12.13.2 Service Portfolio
12.13.3 Recent Developments 84 
12.14 Tjoapack
12.14.1 Company Snapshot
12.14.2 Service Portfolio
12.14.3 Recent Development
12.15 Tripak Pharmaceuticals
12.15.1 Company Snapshot
12.15.2 Service Portfolio
12.15.3 Recent Developments
12.16 Wasdell Packaging Group
12.16.1 Company Snapshot
12.16.2 Product Portfolio
12.16.3 Recent Development
13 Questionnaire
14 Related Reports
List Of Figures
Figure 1 Asia-pacific Contract Pharmaceutical Packaging Market: Segmentation
Figure 2 Asia-pacific Contract Pharmaceutical Packaging Market: Data Triangulation
Figure 3 Asia-pacific Contract Pharmaceutical Packaging Market: Droc Analysis
Figure 4 Asia-pacific Contract Pharmaceutical Packaging Market: Asia-pacific Vs Regional Market Analysis
Figure 5 Asia-pacific Contract Pharmaceutical Packaging Market: Company Research Analysis
Figure 6 Asia-pacific Contract Pharmaceutical Packaging Market: Multivariate Modelling
Figure 7 Asia-pacific Contract Pharmaceutical Packaging Market: Interview Demographics
Figure 8 Asia-pacific Contract Pharmaceutical Packaging Market: Dbmr Market Position Grid
Figure 9 Asia-pacific Contract Pharmaceutical Packaging Market: Application Coverage Grid
Figure 10 Asia-pacific Contract Pharmaceutical Packaging Market: Vendor Share Analysis
Figure 11 Asia-pacific Contract Pharmaceutical Packaging Market: Segmentation
Figure 12 Strong Spending Towards Pharma Industry Is Expected To Drive The Growth Of The Asia-pacific Contract Pharmaceutical Packaging Market In The Forecast Period
Figure 13 The Primary Packaging System Segment Is Expected To Account For The Largest Market Share Of The Asia-pacific Contract Pharmaceutical Packaging Market In 2023 And 2030
Figure 14 Vendor Selection Criteria
Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Asia-pacific Contract Pharmaceutical Packaging Market
Figure 16 Fdi Inflows In Drugs & Pharmaceuticals Activities
Figure 17 Asia-pacific Contract Pharmaceutical Packaging Market: Snapshot (2022)
Figure 18 Asia-pacific Contract Pharmaceutical Packaging Market: Company Share 2022 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings